Vericel Analyst Ratings
BenzingaMar 26 21:14
Analysts Offer Insights on Healthcare Companies: Vor Biopharma (VOR), Inotiv (NOTV) and Vericel (VCEL)
TipRanksMar 26 20:50
Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN), OmniAb (OABI) and Vericel (VCEL)
TipRanksMar 25 09:40
Analysts Conflicted on These Healthcare Names: Vericel (VCEL), Tenet Healthcare (THC) and Veeva Systems (VEEV)
TipRanksMar 1 20:40
Vericel Analyst Ratings
BenzingaMar 1 20:32
Buy Rating Affirmed for Vericel on Strong Financials and Growth Prospects
TipRanksMar 1 19:26
BTIG Keeps Their Buy Rating on Vericel (VCEL)
TipRanksFeb 22 18:25
BTIG Remains a Buy on Vericel (VCEL)
TipRanksFeb 20 19:15
Vericel Upgraded at Truist on Growth Acceleration Potential
Seeking AlphaJan 26 03:44
Vericel Analyst Ratings
BenzingaJan 25 19:28
Vericel Analyst Ratings
BenzingaJan 16 20:18
Leerink Partners Remains a Buy on Vericel (VCEL)
TipRanksJan 11 14:41
BTIG Reaffirms Their Hold Rating on Vericel (VCEL)
TipRanksJan 2 22:54
BTIG Sticks to Its Buy Rating for Vericel (VCEL)
TipRanksDec 31, 2023 18:28
Analysts Offer Insights on Healthcare Companies: Vericel (VCEL), Irhythm Technologies (IRTC) and Meiragtx Holdings (MGTX)
TipRanksDec 26, 2023 10:30
Vericel's Growth Potential and Distinct Product Profiles: The Basis for a Buy Rating
TipRanksNov 22, 2023 23:05
Vericel Stock's Promising Outlook: Buy Rating, Increased Price Target, and High-Growth MedTech Potential
TipRanksNov 10, 2023 19:39
Truist Securities Maintains Hold on Vericel, Raises Price Target to $39
BenzingaNov 10, 2023 05:50
Vericel Analyst Ratings
BenzingaNov 10, 2023 05:49
Hold Rating on Vericel: A Measured Approach on Future Growth Amid Slower NexoBrid Ramp and Valuation Concerns
TipRanksNov 10, 2023 01:42
No Data
No Data